Você pesquisou por y - Revista Brasileira de Ginecologia e Obstetrícia
You searched for:"Flávio Murilo Pinto Sivini"
We found (2) results for your search.Summary
Revista Brasileira de Ginecologia e Obstetrícia. 2001;23(8):499-504
DOI 10.1590/S0100-72032001000800004
Purpose: to evaluate factors that might influence the results of nonphamacological treatment (verbal guidance) in women with clinical mastalgia. Methods: an uncontrolled study of the experimental type was conducted on a sample of 128 women with a clear history of clinical mastalgia treated with verbal guidance. A visual analogue scale for pain was used before and after treatment to evaluate pain intensity and mastalgia was classified into grade I (mild), grade II (moderate) and grade III (severe) according to pain intensity. The Cardiff Breast Score (CBS), modified, was also used to evaluate the clinical response to treatment. Data were analyzed statistically using the chi² test (Epi-Info 6.04). Results: we noted that factors such as parity, menarche, age at first term delivery and breast-feeding had no significant effect (p=0.19, p=0.31, p=0.80 and p=0.54, respectively) on the results of nonpharmacological treatment (verbal guidance). On the other hand, when age was taken into consideration, 26 patients (78.8%) aged 40 years or older were found to benefi more from verbal guidance, with a significant difference (p=0.01) when compared to younger women. Conclusion: reproductive factors such as parity, menarche, age at first term delivery and breast-feeding did not affect the results of nonpharmacological treatment (verbal guidance), whereas the age factor had a specific and significant effect on the results.
Summary
Revista Brasileira de Ginecologia e Obstetrícia. 2001;23(8):499-504
DOI 10.1590/S0100-72032001000800004
Purpose: to evaluate factors that might influence the results of nonphamacological treatment (verbal guidance) in women with clinical mastalgia. Methods: an uncontrolled study of the experimental type was conducted on a sample of 128 women with a clear history of clinical mastalgia treated with verbal guidance. A visual analogue scale for pain was used before and after treatment to evaluate pain intensity and mastalgia was classified into grade I (mild), grade II (moderate) and grade III (severe) according to pain intensity. The Cardiff Breast Score (CBS), modified, was also used to evaluate the clinical response to treatment. Data were analyzed statistically using the chi² test (Epi-Info 6.04). Results: we noted that factors such as parity, menarche, age at first term delivery and breast-feeding had no significant effect (p=0.19, p=0.31, p=0.80 and p=0.54, respectively) on the results of nonpharmacological treatment (verbal guidance). On the other hand, when age was taken into consideration, 26 patients (78.8%) aged 40 years or older were found to benefi more from verbal guidance, with a significant difference (p=0.01) when compared to younger women. Conclusion: reproductive factors such as parity, menarche, age at first term delivery and breast-feeding did not affect the results of nonpharmacological treatment (verbal guidance), whereas the age factor had a specific and significant effect on the results.
Summary
Revista Brasileira de Ginecologia e Obstetrícia. 2001;23(2):77-82
DOI 10.1590/S0100-72032001000200003
Purpose: to evaluate the nonpharmacologic treatment (reassurance) as a first line therapy for women with cyclical mastalgia, and to observe if a prolonged course of pain alters the outcome. Methods: we conducted a noncontrolled experimental study with a sample of 128 eligible women with a clear history of cyclical mastalgia treated with reassurance. A visual linear analogical scale of the pain was used before and after treatment in order to assess its severity and the mastalgias were classified into degrees I (mild), II (moderate) and III (severe) according to the intensity of pain. We also used a modified Cardiff Breast Score (CBS) to assess the clinical response. The data analysis was performed using the chi² test (Epi-Info 6.04 software). Results: we verified a success rate of 59.4% with reassurance, but there was no significant statistical difference between the groups (p = 0.16) with different degrees of mastalgia. The less satisfactory response to the nonpharmacologic treatment in those pacients with a prolonged course of pain was only apparent, since there was no significant statistical difference (p = 0.14). Conclusion: reassurance should be always tried as the first choice treatment for women with cyclical mastalgia, independently of pain intensity. Prolonged course of pain did not alter the outcome.
Summary
Revista Brasileira de Ginecologia e Obstetrícia. 2001;23(2):77-82
DOI 10.1590/S0100-72032001000200003
Purpose: to evaluate the nonpharmacologic treatment (reassurance) as a first line therapy for women with cyclical mastalgia, and to observe if a prolonged course of pain alters the outcome. Methods: we conducted a noncontrolled experimental study with a sample of 128 eligible women with a clear history of cyclical mastalgia treated with reassurance. A visual linear analogical scale of the pain was used before and after treatment in order to assess its severity and the mastalgias were classified into degrees I (mild), II (moderate) and III (severe) according to the intensity of pain. We also used a modified Cardiff Breast Score (CBS) to assess the clinical response. The data analysis was performed using the chi² test (Epi-Info 6.04 software). Results: we verified a success rate of 59.4% with reassurance, but there was no significant statistical difference between the groups (p = 0.16) with different degrees of mastalgia. The less satisfactory response to the nonpharmacologic treatment in those pacients with a prolonged course of pain was only apparent, since there was no significant statistical difference (p = 0.14). Conclusion: reassurance should be always tried as the first choice treatment for women with cyclical mastalgia, independently of pain intensity. Prolonged course of pain did not alter the outcome.